CalciMedica, Inc.

By person

24 insiders · 123 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Flynn James E

10% owner

$25.00M (1)

—

+$25.00M

5,281,713

$4.24M

—

ORBIMED ADVISORS LLC entity

10% owner

$9.00M (1)

—

+$9.00M

4,163,347

$3.34M

—

Clarus Lifesciences III, L.P.

10% owner

$4.00M (1)

—

+$4.00M

1,930,395

$1.55M

—

Middleton Fred A

Director

$3.17M (16)

—

+$3.17M

1,099,786

$883.46K

—

Sanderling Venture Partners VI LP entity

10% owner

$2.52M (7)

—

+$2.52M

977,036

$784.85K

—

Roberts Eric W

CHIEF BUSINESS OFFICER

$644.72K (50)

—

+$644.72K

450,585

$361.95K

—

WILSON ROBERT N

Director

$623.21K (6)

—

+$623.21K

1,604,650

$1.29M

—

Sanderling Venture Partners VI Co Investment Fund LP entity

10% owner

$329.04K (2)

—

+$329.04K

836,779

$672.18K

+11.7%

SHAFFER CHRISTY L

Director

$300.00K (1)

—

+$300.00K

1,606,669

$1.29M

—

Hebbar Sudarshan

Chief Medical Officer

$168.92K (5)

—

+$168.92K

186,025

$149.43K

—

Leheny A. Rachel

CHIEF EXECUTIVE OFFICER

$156.37K (15)

—

+$156.37K

321,155

$257.98K

—

BREUIL ROBERT S

Chief Financial Officer

—

$28.59K (2) scheduled

−$28.59K

35,326

$28.38K

—

BJERKHOLT ERIC

Director

$6.72K (9)

—

+$6.72K

3,684

$2.96K

—

Bardin Stephen

Chief Financial Officer

$4.70K (2)

—

+$4.70K

44,000

$35.35K

+7.3%

Stauderman Kenneth A.

Chief Scientific Officer

$5.81K (2)

$3.65K (1)

+$2.16K

12,944

$10.40K

—

Keyoung Hansoo Michael

Director

—

1,133,596

$910.62K

—

Valence Investments SPV IV LLC entity

10% owner

—

673,098

$540.70K

—

Guerard Frederic

Director

—

90,727

$72.88K

—

Zamiri Parisa

Chief Medical Officer

—

28,982

$23.28K

—

Dunn Michael J.

President and COO

—

11,761

$9.45K

—

Cagle Gerald D.

Director

—

3,322

$2.67K

—

EASTLAND JULIA MARIE

Director

—

1,429

$1.15K

—

ACKERMANN CHRISTINA

Director

—

1,429

$1.15K

—

Sauer Dirk

Director

—

1,429

$1.15K

—

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 13,481,917 to 34,141,460 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

By person

Individual transactions

What was left out